US 12,226,517 B2
Topical compositions and methods to promote optimal dermal white adipose tissue composition in vivo
Ivan Galanin, New York, NY (US)
Appl. No. 17/288,728
Filed by Ivan Galanin, New York, NY (US)
PCT Filed Oct. 24, 2019, PCT No. PCT/US2019/057822
§ 371(c)(1), (2) Date Apr. 26, 2021,
PCT Pub. No. WO2020/086820, PCT Pub. Date Apr. 30, 2020.
Claims priority of provisional application 62/751,222, filed on Oct. 26, 2018.
Prior Publication US 2021/0401728 A1, Dec. 30, 2021
Int. Cl. A61K 36/00 (2006.01); A61K 8/92 (2006.01); A61K 8/9794 (2017.01); A61Q 19/08 (2006.01)
CPC A61K 8/922 (2013.01) [A61K 8/9794 (2017.08); A61Q 19/08 (2013.01); A61K 2800/10 (2013.01); A61K 2800/74 (2013.01)] 2 Claims
 
1. A topical composition effective for increasing superficial dermal fat volume or for decreasing superficial dermal fat volume as needed in a human, comprising: at least one adipogenic agent; at least one lipolytic agent; and at least one penetrant, wherein the at least one lipolytic agent is selected from the group consisting of: Kaempferia parviflora extract, Cyclopia intermedia, and Phaseolus vulgaris extract, and the at least one adipogenic agent is selected from the group consisting of: sunflower seed oil, chia oil, hemp oil, safflower oil, and mixtures thereof.